Bioadhesive delivery systems for mucosal vaccine delivery (Q37805519)

23 August 2017

title

Bioadhesive delivery systems for mucosal vaccine delivery (English)

1 reference

23 August 2017

Barbara C. Baudner

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21039314

18 August 2024

Derek T. O'Hagan

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21039314

18 August 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=21039314

18 August 2024

publication date

2 November 2010

1 reference

Journal of Drug Targeting

23 August 2017

published in

1 reference

23 August 2017

1 reference

23 August 2017

1 reference

23 August 2017

page(s)

752-770

1 reference

Safety of sublingual immunotherapy with a monomeric allergoid in very young children.

23 August 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.529143

Chitosan-based delivery systems for protein therapeutics and antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.529143

Vaccinology: past achievements, present roadblocks and future promises

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.529143

Chitosan-based systems for the delivery of vaccine antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.529143

Proinflammatory responses in the murine brain after intranasal delivery of cholera toxin: implications for the use of AB toxins as adjuvants in intranasal vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.529143

The concomitant use of the LTK63 mucosal adjuvant and of chitosan-based delivery system enhances the immunogenicity and efficacy of intranasally administered vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.529143

Modulation of immune response to group C meningococcal conjugate vaccine given intranasally to mice together with the LTK63 mucosal adjuvant and the trimethyl chitosan delivery system

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.529143

Safety, immunogenicity and efficacy of intranasal, live attenuated influenza vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.529143

Systemic immune responses induced by mucosal administration of lipopeptides without adjuvant

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.529143

Pulmonary delivery of chitosan-DNA nanoparticles enhances the immunogenicity of a DNA vaccine encoding HLA-A*0201-restricted T-cell epitopes of Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.529143

The B-cell system of human mucosae and exocrine glands

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.529143

Induction of secretory immunity and memory at mucosal surfaces

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.529143

Mucosal immunity: induction, dissemination, and effector functions

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.529143

Keynote review: intestinal Peyer's patch M cells and oral vaccine targeting.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.529143

Oral vaccination in man using antigens in particles: current status

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.529143

Immune responses and protection against Bordetella pertussis infection after intranasal immunization of mice with filamentous haemagglutinin in solution or incorporated in biodegradable microparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.529143

Carboxymethyl high amylose starch (CM-HAS) as excipient for Escherichia coli oral formulations

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.529143

Mucosally delivered Salmonella live vector vaccines elicit potent immune responses against a foreign antigen in neonatal mice born to naive and immune mothers

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.529143

Normal structure, function, and histology of mucosa-associated lymphoid tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.529143

Salivary, gut, vaginal and nasal antibody responses after oral immunization with biodegradable microparticles.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.529143

Exploiting M cells for drug and vaccine delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.529143

Effect of chitosan and of N-carboxymethylchitosan on intraocular penetration of topically applied ofloxacin

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.529143

Spray-dried powders of starch and crosslinked poly(acrylic acid) as carriers for nasal delivery of inactivated influenza vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.529143

Repeated vaginal administration of trimeric HIV-1 clade C gp140 induces serum and mucosal antibody responses

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.529143

Mucosal delivery of vaccine antigens and its advantages in pediatrics

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.529143

Effect of chitosan on epithelial permeability and structure

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.529143

Sublingual immunotherapy: what have we learnt from the 'big trials'?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.529143

The global value of vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.529143

Particle size and surface charge affect particle uptake by human dendritic cells in an in vitro model.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.529143

Improving vaccines by incorporating immunological coadjuvants

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.529143

A dilemma for mucosal vaccination: efficacy versus toxicity using enterotoxin-based adjuvants

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.529143

Uptake of microparticles into the epithelium of human nasopharyngeal lymphoid tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.529143

The anatomy of mucosal immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.529143

Mucosal adjuvanticity and immunogenicity of LTR72, a novel mutant of Escherichia coli heat-labile enterotoxin with partial knockout of ADP-ribosyltransferase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.529143

Protein release from alginate matrices

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.529143

Beta7-integrin-independent enhancement of mucosal and systemic anti-HIV antibody responses following combined mucosal and systemic gene delivery.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.529143

M-cell targeted biodegradable PLGA nanoparticles for oral immunization against hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.529143

Lectin anchored stabilized biodegradable nanoparticles for oral immunization 1. Development and in vitro evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.529143

Antibody responses against HIV in rhesus macaques following combinations of mucosal and systemic immunizations with chimeric alphavirus-based replicon particles

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.529143

Mucosal immunisation of murine neonates using whole cell and acellular Pertussis vaccines.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.529143

Uptake through glycoprotein 2 of FimH(+) bacteria by M cells initiates mucosal immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.529143

Sublingual immunization with an HIV subunit vaccine induces antibodies and cytotoxic T cells in the mouse female genital tract.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.529143

Stimulation of human macrophages (THP-1) using Toll-like receptor-2 (TLR-2) agonist decorated nanocarriers

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.529143

Toll-like receptor-2 agonist functionalized biopolymer for mucosal vaccination.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.529143

Cholera as a model for research on mucosal immunity and development of oral vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.529143

Mucosal immunity and vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.529143

Effect of neonatal sublingual vaccination with native or denatured ovalbumin and adjuvant CpG or cholera toxin on systemic and mucosal immunity in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.529143

Induction of protective serum meningococcal bactericidal and diphtheria-neutralizing antibodies and mucosal immunoglobulin A in volunteers by nasal insufflations of the Neisseria meningitidis serogroup C polysaccharide-CRM197 conjugate vaccine mixed

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.529143

Chitosan as a novel nasal delivery system for vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.529143

Chitosan and its use as a pharmaceutical excipient

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.529143

Nasal delivery of chitosan-DNA plasmid expressing epitopes of respiratory syncytial virus (RSV) induces protective CTL responses in BALB/c mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.529143

Strong systemic and mucosal immune responses to surface-modified PLGA microspheres containing recombinant hepatitis B antigen administered intranasally

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.529143

Intranasal immunization with pneumococcal conjugate vaccines with LT-K63, a nontoxic mutant of heat-Labile enterotoxin, as adjuvant rapidly induces protective immunity against lethal pneumococcal infections in neonatal mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.529143

M cell targeting by lectins: a strategy for mucosal vaccination and drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.529143

Poly(?-lactide-co-glycolide)-encapsulated plasmid DNA elicits systemic and mucosal antibody responses to encoded protein after oral administration

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.529143

A new intranasal influenza vaccine based on a novel polycationic lipid--ceramide carbamoyl-spermine (CCS) I. Immunogenicity and efficacy studies in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.529143

High-efficiency intracellular magnetic labeling with novel superparamagnetic-Tat peptide conjugates

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.529143

Biodegradable nanoparticles for oral delivery of peptides: is there a role for polymers to affect mucosal uptake?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.529143

Oral immunization of adult volunteers with microencapsulated enterotoxigenic Escherichia coli (ETEC) CS6 antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.529143

Novel anionic microparticles are a potent adjuvant for the induction of cytotoxic T lymphocytes against recombinant p55 gag from HIV-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.529143

Mucosal immune responses following oral immunization with rotavirus antigens encapsulated in alginate microspheres

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.529143

Safety and immunogenicity of low and high doses of trivalent live cold-adapted influenza vaccine administered intranasally as drops or spray to healthy children

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.529143

Polymeric microspheres for drug delivery to the oral cavity: an in vitro evaluation of mucoadhesive potential.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.529143

Nanoparticles as carriers for nasal vaccine delivery.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.529143

Effect of the degree of quaternization of N-trimethyl chitosan chloride on the permeability of intestinal epithelial cells (Caco-2).

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.529143

A nontoxic chimeric enterotoxin adjuvant induces protective immunity in both mucosal and systemic compartments with reduced IgE antibodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.529143

Mechanisms of antigen uptake for presentation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.529143

Immunological implications of the use of plant lectins for drug and vaccine targeting to the gastrointestinal tract.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.529143

Mistletoe lectins enhance immune responses to intranasally co-administered herpes simplex virus glycoprotein D2.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.529143

Delivery systems and adjuvants for oral vaccines.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.529143

Bioadhesive-based dosage forms: the next generation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.529143

Enhanced mucosal immunoglobulin A response of intranasal adenoviral vector human immunodeficiency virus vaccine and localization in the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.529143

Transient facial nerve paralysis (Bell's palsy) following intranasal delivery of a genetically detoxified mutant of Escherichia coli heat labile toxin

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.529143

Analysis of poly(D,L-lactic-co-glycolic acid) nanosphere uptake by human dendritic cells and macrophages in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.529143

Enhanced mucosal and systemic immune response with intranasal immunization of mice with HIV peptides entrapped in PLG microparticles in combination with Ulex Europaeus-I lectin as M cell target

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.529143

Mucosal delivery of the human immunodeficiency virus-1 Tat protein in mice elicits systemic neutralizing antibodies, cytotoxic T lymphocytes and mucosal IgA.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.529143

Protection against vaginal SIV transmission with microencapsulated vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.529143

Biologically erodable microspheres as potential oral drug delivery systems

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.529143

Intranasal immunization with genetically detoxified diphtheria toxin induces T cell responses in humans: enhancement of Th2 responses and toxin-neutralizing antibodies by formulation with chitosan

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.529143

A mucosal vaccine against diphtheria: formulation of cross reacting material (CRM(197)) of diphtheria toxin with chitosan enhances local and systemic antibody and Th2 responses following nasal delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.529143

Protective levels of diphtheria-neutralizing antibody induced in healthy volunteers by unilateral priming-boosting intranasal immunization associated with restricted ipsilateral mucosal secretory immunoglobulin a

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.529143

Immunization without needles

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.529143

Molecular perspective on tight-junction assembly and epithelial polarity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.529143

Immunization with a soluble recombinant HIV protein entrapped in biodegradable microparticles induces HIV-specific CD8+ cytotoxic T lymphocytes and CD4+ Th1 cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.529143

Type 1 and 2 immunity following vaccination is influenced by nanoparticle size: formulation of a model vaccine for respiratory syncytial virus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.529143

Cross-linked high amylose starch derivatives for drug release. II. Swelling properties and mechanistic study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.529143

Novel chitosan particles and chitosan-coated emulsions inducing immune response via intranasal vaccine delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.529143

Genetically detoxified mutants of heat-labile enterotoxin from Escherichia coli are effective adjuvants for induction of cytotoxic T-cell responses against HIV-1 gag-p55.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.529143

Epithelial M cells: gateways for mucosal infection and immunization

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.529143

Mucosal vaccines: the promise and the challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.529143

Uptake of poly(D,L-lactic-co-glycolic acid) microspheres by antigen-presenting cells in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.529143

Adjuvant activity of chitin derivatives in mice and guinea-pigs.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.529143

Immunological activity of chitin and its derivatives.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.529143

Synthetic peptides entrapped in microparticles can elicit cytotoxic T cell activity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.529143

A novel M cell-specific carbohydrate-targeted mucosal vaccine effectively induces antigen-specific immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.529143

Long-term antibody responses in mice following subcutaneous immunization with ovalbumin entrapped in biodegradable microparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.529143

Recent advances in the discovery and delivery of vaccine adjuvants

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.529143

Microparticles as potentially orally active immunological adjuvants

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.529143

Novel approaches to pediatric vaccine delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.529143

Microparticles as vaccine adjuvants and delivery systems

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.529143

Biodegradable microspheres in drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.529143

Induction of Broad and Potent Anti-Human Immunodeficiency Virus Immune Responses in Rhesus Macaques by Priming with a DNA Vaccine and Boosting with Protein-Adsorbed Polylactide Coglycolide Microparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.529143

The adjuvant effect of a non-toxic mutant of heat-labile enterotoxin of Escherichia coli for the induction of measles virus-specific CTL responses after intranasal co-immunization with a synthetic peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.529143

Sublingual immunotherapy: update 2006.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.529143

Safety of the trivalent, cold-adapted influenza vaccine in preschool-aged children

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.529143

Probing the structure-activity relationship of Escherichia coli LT-A by site-directed mutagenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.529143

A genetically detoxified derivative of heat-labile Escherichia coli enterotoxin induces neutralizing antibodies against the A subunit

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.529143

Mucosal vaccines: non toxic derivatives of LT and CT as mucosal adjuvants.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.529143

Improving protein therapeutics with sustained-release formulations

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.529143

Structure and mucosal adjuvanticity of cholera and Escherichia coli heat-labile enterotoxins

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.529143

Induction of systemic and mucosal immune response in cattle by intranasal administration of pig serum albumin in alginate microparticles.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.529143

Phagocytosis of antigens by Langerhans cells in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.529143

Intranasal administration of the synthetic polypeptide from the C-terminus of the circumsporozoite protein of Plasmodium berghei with the modified heat-labile toxin of Escherichia coli (LTK63) induces a complete protection against malaria challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.529143

Oral gene delivery with chitosan--DNA nanoparticles generates immunologic protection in a murine model of peanut allergy.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.529143

Starch microparticles as vaccine adjuvant

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.529143

Use of an oral diphtheria vaccine in human.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.529143

The use of mucoadhesive polymers in buccal drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.529143

Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.529143

Assessment of chitosan derivatives as buccal and vaginal penetration enhancers

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.529143

TMC-MCC (N-trimethyl chitosan-mono-N-carboxymethyl chitosan) nanocomplexes for mucosal delivery of vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.529143

Mono-N-carboxymethyl chitosan (MCC) and N-trimethyl chitosan (TMC) nanoparticles for non-invasive vaccine delivery.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.529143

Chitosans as absorption enhancers for poorly absorbable drugs 2: mechanism of absorption enhancement

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.529143

Poly (lactide-co-glycolide) particles of different physicochemical properties and their uptake by peyer's patches in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.529143

Anionic microparticles are a potent delivery system for recombinant antigens from Neisseria meningitidis serotype B.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.529143

Mucosal immunization with HIV-1 gag DNA on cationic microparticles prolongs gene expression and enhances local and systemic immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.529143

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.529143

The basics and underlying mechanisms of mucoadhesion

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.529143

CCR7-CCL19/CCL21-regulated dendritic cells are responsible for effectiveness of sublingual vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.529143

Sublingual vaccination with influenza virus protects mice against lethal viral infection

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.529143

Phase I evaluation of intranasal trivalent inactivated influenza vaccine with nontoxigenic Escherichia coli enterotoxin and novel biovector as mucosal adjuvants, using adult volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.529143

Starch microparticles as an adjuvant in immunisation: effect of route of administration on the immune response in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.529143

Vaccination with dendritic cells pulsed in vitro with tumor antigen conjugated to cholera toxin efficiently induces specific tumoricidal CD8+ cytotoxic lymphocytes dependent on cyclic AMP activation of dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.529143

Effective induction of naive and recall T-cell responses by targeting antigen to human dendritic cells via a humanized anti-DC-SIGN antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.529143

Enteral immunization and challenge of volunteers given enterotoxigenic E. coli CFA/II encapsulated in biodegradable microspheres

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.529143

Preparation and in vivo study of dry powder microspheres for nasal immunization

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.529143

Formulation, characterization and release studies of alginate microspheres encapsulated with tetanus toxoid

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.529143

Mucoadhesive properties of carbopol or chitosan-coated liposomes and their effectiveness in the oral administration of calcitonin to rats

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.529143

Oral drug absorption enhancement by chitosan and its derivatives

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.529143

Effects of N-trimethyl chitosan chloride, a novel absorption enhancer, on caco-2 intestinal epithelia and the ciliary beat frequency of chicken embryo trachea

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.529143

Chitin--the undisputed biomolecule of great potential.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.529143

Phagocytosis and phagosomal fate of surface-modified microparticles in dendritic cells and macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.529143

Combinations of protein polysaccharide conjugate vaccines for intranasal immunization.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.529143

Intranasal immunization of mice with herpes simplex virus type 2 recombinant gD2: the effect of adjuvants on mucosal and serum antibody responses

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.529143

Potency of a genetically detoxified mucosal adjuvant derived from the heat-labile enterotoxin of Escherichia coli (LTK63) is not adversely affected by the presence of preexisting immunity to the adjuvant.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.529143

Transport of chitosan microparticles for mucosal vaccine delivery in a human intestinal M-cell model.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.529143

Cutting edge: the mucosal adjuvant cholera toxin redirects vaccine proteins into olfactory tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.529143

Bioadhesive microspheres as a controlled drug delivery system.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.529143

PLA-PEG particles as nasal protein carriers: the influence of the particle size.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.529143

Oral immunization with an anti-idiotypic antibody to the exoglycolipid antigen protects against experimental Chlamydia trachomatis infection

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.529143

Sublingual immunotherapy for allergic rhinitis: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.529143

Pathogen recognition and development of particulate vaccines: does size matter?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.529143

Mutants in the ADP-ribosyltransferase cleft of cholera toxin lack diarrheagenicity but retain adjuvanticity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.529143

Mucosal vaccines: novel advances in technology and delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.529143

Oral mucosal drug delivery: clinical pharmacokinetics and therapeutic applications

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.529143

Intestinal Mucins in Health and Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.529143

Bioadhesive polymeric platforms for transmucosal drug delivery systems – a review

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.529143

Nanoparticles based on N-trimethylchitosan: Evaluation of absorption properties using in vitro (Caco-2 cells) and ex vivo (excised rat jejunum) models

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.529143

Immune response by nasal delivery of hepatitis B surface antigen and codelivery of a CpG ODN in alginate coated chitosan nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.529143

Evaluation of the immune response following a short oral vaccination schedule with hepatitis B antigen encapsulated into alginate-coated chitosan nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.529143

10.3109/1061186X.2010.529143

21 January 2018

Identifiers

DOI

1 reference

23 August 2017

1 reference